CoChat

Effects of Chronic D-Serine Elevation on Animal Models of Depression and Anxiety-Related Behavior

Open access
Otte, David-Marian, Barcena de Arellano, Maria Luisa, Bilkei-Gorzo, Andras, Albayram, Önder, Imbeault, Sophie, Jeung, Haang, Alferink, Judith, Zimmer, Andreas · 2013 · PLoS ONE
Cited by 68

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

NMDA receptors are activated after binding of the agonist glutamate to the NR2 subunit along with a co-agonist, either L-glycine or D-serine, to the NR1 subunit. There is substantial evidence to suggest that D-serine is the most relevant co-agonist in forebrain regions and that alterations in D-serine levels contribute to psychiatric disorders. D-serine is produced through isomerization of L-serine by serine racemase (Srr), either in neurons or in astrocytes. It is released by astrocytes by an activity-dependent mechanism involving secretory vesicles. In the present study we generated transgenic mice (SrrTg) expressing serine racemase under a human GFAP promoter. These mice were biochemically and behaviorally analyzed using paradigms of anxiety, depression and cognition. Furthermore, we investigated the behavioral effects of long-term administration of D-serine added to the drinking water. Elevated brain D-serine levels in SrrTg mice resulted in specific behavioral phenotypes in the forced swim, novelty suppression of feeding and olfactory bulbectomy paradigms that are indicative of a reduced proneness towards depression-related behavior. Chronic dietary D-serine supplement mimics the depression-related behavioral phenotype observed in SrrTg mice. Our results suggest that D-serine supplementation may improve mood disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0067131

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 70

  1. F Li, 2009, Memory and the NMDA receptors, N Engl J Med, 361, 302, 10.1056/NEJMcibr0902052 · DOI · Paper page
  2. JA Kemp, 1993, The glycine site of the NMDA receptor–five years on, Trends Pharmacol Sci, 14, 20, 10.1016/0165-6147(93)90108-V · DOI · Paper page
  3. H Wolosker, 1999, Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission, Proc Natl Acad Sci U S A, 96, 13409, 10.1073/pnas.96.23.13409 · DOI · Paper page
  4. DE Baranano, 2001, Atypical neural messengers, Trends Neurosci, 24, 99, 10.1016/S0166-2236(00)01716-1 · DOI · Paper page
  5. JP Mothet, 2000, D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor, Proc Natl Acad Sci U S A, 97, 4926, 10.1073/pnas.97.9.4926 · DOI · Paper page
  6. PM Kim, 2005, Serine racemase: activation by glutamate neurotransmission via glutamate receptor interacting protein and mediation of neuronal migration, Proc Natl Acad Sci U S A, 102, 2105, 10.1073/pnas.0409723102 · DOI · Paper page
  7. AJ Berger, 1998, Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses, J Neurophysiol, 80, 3336, 10.1152/jn.1998.80.6.3336 · DOI · Paper page
  8. M Martina, 2003, D-Serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneurons, J Physiol, 548, 411, 10.1113/jphysiol.2002.037127 · doi:10.1113/jphysiol.2002.037127
  9. R Lim, 2004, Blockade of glycine transporter-1 (GLYT-1) potentiates NMDA receptor-mediated synaptic transmission in hypoglossal motorneurons, J Neurophysiol, 92, 2530, 10.1152/jn.01123.2003 · DOI
  10. GG Kinney, 2003, The glycine transporter type 1 inhibitor N-[3-(4′-fluorophenyl)-3-(4′-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior, J Neurosci, 23, 7586, 10.1523/JNEUROSCI.23-20-07586.2003 · DOI · Paper page
  11. L Chen, 2003, Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo, J Neurophysiol, 89, 691, 10.1152/jn.00680.2002 · DOI · Paper page
  12. R Bergeron, 1998, Modulation of N-methyl-D-aspartate receptor function by glycine transport, Proc Natl Acad Sci U S A, 95, 15730, 10.1073/pnas.95.26.15730 · DOI · Paper page
  13. A Hashimoto, 1992, The presence of free D-serine in rat brain, FEBS Lett, 296, 33, 10.1016/0014-5793(92)80397-Y · DOI · Paper page
  14. A Hashimoto, 1993, Endogenous D-serine in rat brain: N-methyl-D-aspartate receptor-related distribution and aging, J Neurochem, 60, 783, 10.1111/j.1471-4159.1993.tb03219.x · DOI · Paper page
  15. T Matsui, 1995, Functional comparison of D-serine and glycine in rodents: the effect on cloned NMDA receptors and the extracellular concentration, J Neurochem, 65, 454, 10.1046/j.1471-4159.1995.65010454.x · DOI · Paper page
  16. T Priestley, 1995, Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells, Mol Pharmacol, 48, 841
  17. AM Thomson, 1989, Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices, Nature, 338, 422, 10.1038/338422a0 · DOI · Paper page
  18. ER Stevens, 2003, D-serine and serine racemase are present in the vertebrate retina and contribute to the physiological activation of NMDA receptors, Proc Natl Acad Sci U S A, 100, 6789, 10.1073/pnas.1237052100 · DOI · Paper page
  19. V Baptista, 2005, Glycine binding site of the synaptic NMDA receptor in subpostremal NTS neurons, J Neurophysiol, 94, 147, 10.1152/jn.00927.2004 · doi:10.1152/jn.00927.2004
  20. T Papouin, 2012, Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists, Cell, 150, 633, 10.1016/j.cell.2012.06.029 · DOI · Paper page
  21. H Wolosker, 1999, Purification of serine racemase: biosynthesis of the neuromodulator D-serine, Proc Natl Acad Sci U S A, 96, 721, 10.1073/pnas.96.2.721 · DOI · Paper page
  22. J De Miranda, 2000, Human serine racemase: moleular cloning, genomic organization and functional analysis, Gene, 256, 183, 10.1016/S0378-1119(00)00356-5 · DOI
  23. J De Miranda, 2002, Cofactors of serine racemase that physiologically stimulate the synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine, Proc Natl Acad Sci U S A, 99, 14542, 10.1073/pnas.222421299 · DOI · Paper page
  24. MA Benneyworth, 2012, Cell selective conditional null mutations of serine racemase demonstrate a predominate localization in cortical glutamatergic neurons, Cell Mol Neurobiol, 32, 613, 10.1007/s10571-012-9808-4 · DOI · Paper page
  25. JT Coyle, 2003, Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia, Ann N Y Acad Sci, 1003, 318, 10.1196/annals.1300.020 · DOI · Paper page
  26. K Hashimoto, 2007, Increased levels of glutamate in brains from patients with mood disorders, Biol Psychiatry, 62, 1310, 10.1016/j.biopsych.2007.03.017 · DOI · Paper page
  27. I Bendikov, 2007, A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia, Schizophr Res, 90, 41, 10.1016/j.schres.2006.10.010 · DOI · Paper page
  28. EJ Duncan, 2004, Effects of D-cycloserine on negative symptoms in schizophrenia, Schizophr Res, 71, 239, 10.1016/j.schres.2004.03.013 · DOI
  29. K Laake, 2002, D-cycloserine for Alzheimer's disease, Cochrane Database Syst Rev, CD003153
  30. JT Kantrowitz, 2010, High dose D-serine in the treatment of schizophrenia, Schizophr Res, 121, 125, 10.1016/j.schres.2010.05.012 · DOI · Paper page
  31. T Lopes, 1997, Chronic administration of NMDA glycine partial agonists induces tolerance in the Porsolt swim test, Pharmacol Biochem Behav, 58, 1059, 10.1016/S0091-3057(97)00302-X · DOI
  32. OA Onur, 2010, The N-methyl-D-aspartate receptor co-agonist D-cycloserine facilitates declarative learning and hippocampal activity in humans, Biol Psychiatry, 67, 1205, 10.1016/j.biopsych.2010.01.022 · DOI
  33. AC Basu, 2009, Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior, Mol Psychiatry, 14, 719, 10.1038/mp.2008.130 · DOI · Paper page
  34. O Malkesman, 2011, Acute d-serine treatment produces antidepressant-like effects in rodents, Int J Neuropsychopharmacol, 1
  35. C Nolte, 2001, GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue, Glia, 33, 72, 10.1002/1098-1136(20010101)33:1<72::AID-GLIA1007>3.0.CO;2-A · doi:10.1002/1098-1136(20010101)33:1<72::aid-glia1007>3.0.co;2-a
  36. LZ Wang, 2003, Spatiotemporal relationships among D-serine, serine racemase, and D-amino acid oxidase during mouse postnatal development, Acta Pharmacol Sin, 24, 965
  37. M Horio, 2011, Levels of D-serine in the brain and peripheral organs of serine racemase (Srr) knock-out mice, Neurochem Int, 59, 853, 10.1016/j.neuint.2011.08.017 · DOI
  38. SL Grant, 2006, Determination of d-serine and related neuroactive amino acids in human plasma by high-performance liquid chromatography with fluorimetric detection, J Chromatogr B Analyt Technol Biomed Life Sci, 844, 278, 10.1016/j.jchromb.2006.07.022 · DOI
  39. A Bilkei-Gorzo, 2007, Preproenkephalin knockout mice show no depression-related phenotype, Neuropsychopharmacology, 32, 2330, 10.1038/sj.npp.1301370 · DOI
  40. RD Porsolt, 1977, Behavioral despair in mice: a primary screening test for antidepressants, Arch Int Pharmacodyn Ther, 229, 327
  41. J Rochford, 1997, Behavioral reactivity to aversive stimuli in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: effects of diazepam and FG-7142, Psychopharmacology (Berl), 132, 145, 10.1007/s002130050330 · DOI
  42. A Bilkei-Gorzo, 2002, Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene, J Neurosci, 22, 10046, 10.1523/JNEUROSCI.22-22-10046.2002 · DOI · Paper page
  43. E Noirot, 1972, Ultrasounds and maternal behavior in small rodents, Dev Psychobiol, 5, 371, 10.1002/dev.420050410 · DOI · Paper page
  44. SA Brunelli, 1994, Hypothermic vocalizations of rat pups (Rattus norvegicus) elicit and direct maternal search behavior, J Comp Psychol, 108, 298, 10.1037/0735-7036.108.3.298 · doi:10.1037/0735-7036.108.3.298 · Paper page
  45. CR Gardner, 1985, Distress vocalization in rat pups. A simple screening method for anxiolytic drugs, J Pharmacol Methods, 14, 181, 10.1016/0160-5402(85)90031-2 · DOI · Paper page
  46. KA Miczek, 1995, Aggression, anxiety and vocalizations in animals: GABAA and 5-HT anxiolytics, Psychopharmacology (Berl), 121, 38, 10.1007/BF02245590 · DOI · Paper page
  47. WH Morse, 1958, Some factors involved in the stimulus control of operant behavior, J Exp Anal Behav, 1, 103, 10.1901/jeab.1958.1-103 · DOI
  48. R Morris, 1984, Developments of a water-maze procedure for studying spatial learning in the rat, J Neurosci Methods, 11, 47, 10.1016/0165-0270(84)90007-4 · DOI · Paper page
  49. IE Papageorgiou, 2011, Redistribution of astrocytic glutamine synthetase in the hippocampus of chronic epileptic rats, Glia, 59, 1706, 10.1002/glia.21217 · DOI
  50. I Suarez, 2002, Glutamine synthetase in brain: effect of ammonia, Neurochem Int, 41, 123, 10.1016/S0197-0186(02)00033-5 · DOI · Paper page
  51. A Martinez-Hernandez, 1977, Glutamine synthetase: glial localization in brain, Science, 195, 1356, 10.1126/science.14400 · DOI · Paper page
  52. K Hallermayer, 1981, Cellular localization and regulation of glutamine synthetase in primary cultures of brain cells from newborn mice, J Neurochem, 37, 43, 10.1111/j.1471-4159.1981.tb05289.x · DOI · Paper page
  53. P Skolnick, 2009, Glutamate-based antidepressants: 20 years on, Trends Pharmacol Sci, 30, 563, 10.1016/j.tips.2009.09.002 · DOI · Paper page
  54. L Welberg, 2010, Psychiatric disorders: Ketamine modifies mood through mTOR, Nat Rev Neurosci, 11, 666, 10.1038/nrn2916 · DOI · Paper page
  55. LM Rowland, 2005, Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study, Am J Psychiatry, 162, 394, 10.1176/appi.ajp.162.2.394 · DOI · Paper page
  56. JP Kelly, 1997, The olfactory bulbectomized rat as a model of depression: an update, Pharmacol Ther, 74, 299, 10.1016/S0163-7258(97)00004-1 · DOI · Paper page
  57. RE Adamec, 1999, Unilateral block of NMDA receptors in the amygdala prevents predator stress-induced lasting increases in anxiety-like behavior and unconditioned startle–effective hemisphere depends on the behavior, Physiol Behav, 65, 739, 10.1016/S0031-9384(98)00225-X · DOI
  58. L Heimer, 1968, Synaptic distribution of centripetal and centrifugal nerve fibres in the olfactory system of the rat. An experimental anatomical study, J Anat, 103, 413
  59. A Rex, 1998, Pharmacological evaluation of a modified open-field test sensitive to anxiolytic drugs, Pharmacol Biochem Behav, 59, 677, 10.1016/S0091-3057(97)00461-9 · DOI
  60. RJ Rodgers, 2002, Contrasting phenotypes of C57BL/6JOlaHsd, 129S2/SvHsd and 129/SvEv mice in two exploration-based tests of anxiety-related behaviour, Physiol Behav, 77, 301, 10.1016/S0031-9384(02)00856-9 · DOI
  61. R Minkeviciene, 2008, Cognition-enhancing and anxiolytic effects of memantine, Neuropharmacology, 54, 1079, 10.1016/j.neuropharm.2008.02.014 · DOI
  62. JT Winslow, 1990, Rat pup isolation calls are reduced by functional antagonists of the NMDA receptor complex, Eur J Pharmacol, 190, 11, 10.1016/0014-2999(90)94107-9 · DOI
  63. L Santarelli, 2003, Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants, Science, 301, 805, 10.1126/science.1083328 · DOI · Paper page
  64. JP Mothet, 2005, Glutamate receptor activation triggers a calcium-dependent and SNARE protein-dependent release of the gliotransmitter D-serine, Proc Natl Acad Sci U S A, 102, 5606, 10.1073/pnas.0408483102 · DOI · Paper page
  65. P Bado, 2011, Effects of low-dose D-serine on recognition and working memory in mice, Psychopharmacology (Berl), 218, 461, 10.1007/s00213-011-2330-4 · DOI
  66. A Hashimoto, 2004, Effect of systemic administration of D-serine on the levels of D- and L-serine in several brain areas and periphery of rat, Eur J Pharmacol, 495, 153, 10.1016/j.ejphar.2004.05.036 · DOI
  67. Z Zhang, 2008, Bell-shaped D-serine actions on hippocampal long-term depression and spatial memory retrieval, Cereb Cortex, 18, 2391, 10.1093/cercor/bhn008 · DOI · Paper page
  68. T Shimazaki, 2010, D-Serine and a glycine transporter-1 inhibitor enhance social memory in rats, Psychopharmacology (Berl), 209, 263, 10.1007/s00213-010-1794-y · DOI
  69. R Panizzutti, 2005, The pharmacological stimulation of NMDA receptors via co-agonist site: an fMRI study in the rat brain, Neurosci Lett, 380, 111, 10.1016/j.neulet.2005.01.062 · DOI
  70. JC Platel, 2009, GFAP-GFP neural progenitors are antigenically homogeneous and anchored in their enclosed mosaic niche, Glia, 57, 66, 10.1002/glia.20735 · DOI · Paper page

Cited by

See all 68

Metadata

Authors
Otte, D.-M., Barcena de Arellano, M. L., Bilkei-Gorzo, A., Albayram, Ö., Imbeault, S., Jeung, H., Alferink, J., & Zimmer, A.
Venue
PLoS ONE
Published
2013-06-21
Volume
8
Issue
6
Pages
e67131
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1989104082
Cited by
68
References
14
FWCI
1.07
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Chronic D-Serine Elevation on Animal Models of Depression and Anxiety-Related Behavior. https://app.cochat.ai/papers/10.1371/journal.pone.0067131
The paper
Otte, D.-M., Barcena de Arellano, M. L., Bilkei-Gorzo, A., Albayram, Ö., Imbeault, S., Jeung, H., Alferink, J., & Zimmer, A. (2013). Effects of Chronic D-Serine Elevation on Animal Models of Depression and Anxiety-Related Behavior. PLoS ONE. https://doi.org/10.1371/journal.pone.0067131

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.